Cross-Talk between Mitochondria and Proteasomes in Diseases

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (15 September 2021) | Viewed by 11168

Special Issue Editor


E-Mail
Guest Editor
Department of Biochemistry and Molecular Cell Biology, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China
Interests: ageing; proteasome; neurodegenerative diseases; life span in yeast

Special Issue Information

Dear Colleagues,

Proteasome activity and mitochondrial homeostasis came to the front line of biomedical research due to their involvement and impairment in many diseases, including neurodegenerative and cardiovascular diseases. The ubiquitin-proteasome system (UPS) and autophagy play a crucial role in the maintenance of protein homeostasis through their ability to eliminate damaged and misfolded proteins. Their activities are vital for numerous cellular processes that are regulated by the temporally specific degradation of pathway components. In most eukaryotic cells, mitochondria form a dynamic network and are subject to continuous fission and fusion. Unopposed fission or fusion, in response to the deletion of specific factors, results in a reduction in mitochondrial functionality. The fusion of mitochondria promotes repair and complementation processes, while damaged mitochondria are segregated from the network by fission, promoting mitophagy. Imbalanced mitochondrial dynamics and function are crucial underlying mechanisms for cellular toxicity, also leading to proteasome overload and reduced proteasome function. On the other hand, proteasome impairment results in mitochondrial dysfunction. Thus, there is a mutual interdependence between mitochondrial and proteasomal function. In this Special Issue, advances will be presented in our understanding of the relationship between mitochondria and proteasomes, particularly focusing on their role in diseases and describing possible therapeutic strategies.

Dr. Yanhua Yao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondria function
  • mitochondria dynamics
  • proteasome
  • ageing
  • diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 1819 KiB  
Review
The Multifaceted Regulation of Mitochondria in Ferroptosis
by Hao Wu, Fengli Wang, Na Ta, Ting Zhang and Weihua Gao
Life 2021, 11(3), 222; https://doi.org/10.3390/life11030222 - 10 Mar 2021
Cited by 80 | Viewed by 10391
Abstract
Ferroptosis is characterized as a novel form of regulated cell death, which is initiated by the lethal accumulation of lipid peroxidation catalyzed by cellular labile free iron. This iron driven cell death sharply differs from other well characterized forms of regulated cell death [...] Read more.
Ferroptosis is characterized as a novel form of regulated cell death, which is initiated by the lethal accumulation of lipid peroxidation catalyzed by cellular labile free iron. This iron driven cell death sharply differs from other well characterized forms of regulated cell death at morphological, genetic and biochemical levels. Increasing research has elaborated a high relevance between dysregulated ferroptosis and the pathogenesis of degenerative diseases and organs injury in human patients. Additionally, targeted induction of ferroptosis is considered as a potentially therapeutic design for the clinical intervention of other therapy-resistant cancers. It is well understood that mitochondria, the cellular powerhouse, determine several types of regulated cell death. Recently, compromised mitochondrial morphology and functionalities have been primarily formulated in ferroptosis. Several mitochondria associated proteins and metabolic processes have been elaborated to fine-tune ferroptotic program. Herein, we critically review the recent advances in this booming field, with focus on summarizing the multifaceted mitochondrial regulation of ferroptosis and providing a perspective on the potential biochemical basis. Finally, we are attempting to shed light on an integrative view on the possibility of mitochondria- and ferroptosis-targeting therapeutics as novel treatment designs for the intervention of ferroptosis related diseases. Full article
(This article belongs to the Special Issue Cross-Talk between Mitochondria and Proteasomes in Diseases)
Show Figures

Figure 1

Back to TopTop